Many people in technical fields eventually face a question: do I stay a deep specialist, or move toward leading teams and strategy? The career of Reshma Kewalramani, a physician-scientist who became the CEO of Vertex Pharmaceuticals, offers a useful case study. Her field is biotech, but the lessons apply to developers, engineers, and data professionals.
TL;DR
She moved from clinical medicine and research to industry, then into executive leadership, by spotting a gap and acting on it.
Lesson 1: Build depth first
She trained as a physician, completed a nephrology fellowship, and ran her own research lab. That expertise later let her evaluate scientific and business decisions with credibility.
Lesson 2: Notice where impact is limited
Her academic lab focused on basic discoveries, but she saw that turning discoveries into medicines happens in industry. For developers, this is like realizing your work would reach more users in a different environment.
Lesson 3: Add the missing skills deliberately
In 2015 she completed Harvard Business School’s General Management Program to formalize her executive skills. Technical professionals can do the same with management or product training.
Lesson 4: Take calculated risks
She left Boston for California in 2004 to join Amgen, even with young twins at home. It was uncertain, but it expanded her impact.
Lesson 5: Ask better questions
She has said that knowing how to ask the right questions matters more than having all the answers. That fits well with team leadership, code reviews, and architecture discussions.
Her Path at a Glance
2004: Amgen
2017: Vertex
2018: Chief Medical Officer
2019: Named successor to Jeffrey Leiden
2020: CEO
Outcomes
Vertex has expanded beyond cystic fibrosis and won approvals for CASGEVY, the first CRISPR-based gene-editing therapy, and Journavx, a non-opioid pain medicine.
Top comments (0)